Dyne therapeutics stock
WebApr 10, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they … WebJan 10, 2024 · The upgrade of Dyne Therapeutics, Inc. to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...
Dyne therapeutics stock
Did you know?
WebHere's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now Zacks - Fri Dec 9, 2024 . Dyne Therapeutics, Inc. (DYN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement... WebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
WebApr 11, 2024 · Dyne Therapeutics Trading Down 6.0 %. DYN stock opened at $8.82 on Tuesday. The firm has a 50 day moving average of $12.59 and a 200-day moving … WebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.
WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 … WebOct 4, 2024 · Dyne Therapeutics (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, visits ...
WebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular …
WebApr 7, 2024 · What is Dyne Therapeutics Inc Ordinary Shares’s stock style? DYN’s stock style is Small Value. Style is an investment factor that has a meaningful impact on … call huggybuddy freeWebOct 4, 2024 · Dyne Therapeutics (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with … cobbling together elements from the previousWebMar 29, 2024 · Here's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now. Dyne Therapeutics, Inc. (DYN) appears to have found support after losing … cobbling togetherWebARF Manager. Genocea Biosciences. Sep 2024 - Feb 20243 years 6 months. Cambridge, MA. call huggy wuggy for freeWebApr 6, 2024 · Dyne Therapeutics. stock was originally listed at a price of $23.90 in Sep 17, 2024. If you had invested in Dyne Therapeutics stock at $23.90, your return over the last 2 years would have been -61.88%, for an annualized return of -38.26% (not including any dividends or dividend reinvestments). cobbling up meaningWebSep 6, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to … cobb link busWebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular diseases. Read the full story here. cobbling throat